基于β-环氧德克斯的皮克林乳液以输送α-托科菲醇:抗氧化稳定性和生物可访问性
Caiyun Cheng1, Chao Yuan1, Bo Cui1
1State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China; School of Food Science and Engineering, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China.
Food chemistry
|November 24, 2023
概括
与单独的β-cyclopodextrin相比,丁甲/β-cyclopodextrin皮克林乳液提供了较强的抗氧化稳定性和更好的消化释放. 这种配方显示出改善营养供应和生物可用性的潜力.
科学领域:
- 食品科学与技术 食品科学与技术
- 合体和表面化学
- 材料科学 材料科学 材料科学
背景情况:
- 皮克林乳液稳定于β-cyclodextrin (β-CD),容易发生氧化降解.
- 丁甲 (CIN) 可能会增强β-CD皮克林乳液的稳定性和功能.
研究的目的:
- 在氧化和消化条件下制备和研究肉甲/β-环德 (CIN/β-CD) 皮克林乳液的稳定性.
- 为了比较CIN/β-CD皮克林乳液与β-CD皮克林乳液的性能.
主要方法:
- 准备β-CD和CIN/β-CD皮克林乳液.
- 氧化稳定性的评估使用麦隆迪阿尔海德 (MDA) 值.
- 研究体外消化行为,包括自由脂肪酸 (FFA) 的释放.
- 对α-托科菲罗尔输送的药理动力学分析.
主要成果:
- CIN/β-CD复合材料在油水界面表现出优异的分散,形成了一个更稳定的界面层.
- 与β-CD皮克林乳液相比,CIN/β-CD皮克林乳液对氧化敏感性明显较低 (MDA值较低).
- 消化实验显示,在小肠中释放内部油相,FFA释放率为44.32±1.08%.
- 药理动力学研究表明,在服用CIN/β-CD皮克林乳液5小时后,α-托科菲罗尔的峰值度 (Cmax) 为64.32±6.45mg/L (Tmax).
结论:
- 将肉甲纳入β-环氧德林皮克林乳液中显著提高了界面稳定性和氧化抵抗力.
- CIN/β-CD皮克林乳液促进了小肠中封装的油相成分的受控释放.
- 开发的CIN/β-CD皮克林乳液显示出有望提高像α-托哥菲醇这样的脂性化合物的生物可用性.
相关概念视频
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...


